America Clinical Trials, originally founded in 2002 as a department of the Metabolic Institute of America, has developed into a major research institute bearing its own name in 2012. ACT is led by nationally-recognized medical metabolic leader, Yehuda Handelsman, MD as principal investigator and in coordination with other physician leaders serving as investigators for various studies.
To benefit the medical scientific community and improve healthcare through advancement of clinical research.
To constantly improve our knowledge and innovation in research for the benefit of public health and supporters.
To partner with the most advanced medical development companies to bring new management modalities to healthcare.
To provide a state of the art facility for our clinical research to the betterment of our patients and sponsors.
To help develop the best and safest therapies for the future.